Asia Pacific Dietary Supplements Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Vitamins, Minerals, Proteins and Amino Acids, Probiotics, Blends, and Others), Form (Tablets, Capsules and Softgels, Powders, and Others), and Distribution Channel (Supermarkets and Hypermarkets, Specialty Stores, Online Retail, and Others)
The Asia Pacific dietary supplements market is expected to grow from US$ 91,191.59 million in 2021 to US$ 1,40,493.28 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. In recent years, the market has experienced various technological advancements. For instance, traditional hard and soft gelatin capsules, lozenges, tablets, powders, and liquids are followed by several other types of supplement forms, such as gummies, bilayer tablets, or granules. Due to increased product innovation and rising consumer desire for personalization in the supplement sector, consumers have access to a diverse selection of delivery forms to suit their specific lifestyles and preferences, providing the industry with the option to solve swallowing issues and cater to increased consumer demand for customization. As a result, manufacturers are focusing on innovations and are launching new products in different forms and flavors. For instance, Abbott Laboratories has recently introduced Duphalac Bears in India. This product adheres to FSSAI regulations, has the benefits of a trusted prebiotic, and promotes the growth of healthy bacteria in the digestive system while decreasing hostile bacteria levels. The company also introduced strawberry-flavored food supplements in India to support the company's line of dietary supplements available in this country. Further, in April 2019, Amway introduced a new probiotic supplement named Nutrilite Balance Within. This product is a dietary supplement that helps the human body with clinically established probiotic levels for gut and immunological health. Due to the factors mentioned above, the Asia Pacific dietary supplements market is expected to witness new opportunities for growth in the near future.
In Asia Pacific, India got severely impacted due to the COVID-19 pandemic. The COVID-19 pandemic caused a significant economic loss in the region. The emergence of new COVID-19 pandemic waves in India and other Asian economies has prolonged the effect of pandemics upon GDP. The ongoing COVID-19 pandemic caused huge disruptions in the growth of various industries of Asia Pacific. However, the dietary supplements market witnessed an increase in the dietary supplements market as these supplements are beneficial in boosting the immune system. In addition, investment by existing players and penetration of new players to tap the prevailing opportunities and cater to soaring demand for natural, healthy, clean-label products in post-pandemic times.
Based on distribution channel, the specialty stores segment led the Asia Pacific dietary supplements market in 2020. A specialty store is a shop or store that carries a wide range of products within a relatively small product category. The store includes pharmacies and nutrition stores, where dietary supplements are easily available and offer excellent customer service, exclusive pricing, and premium deals. Specialty stores keep a smaller number of products as they sell only products of a specific brand. The staff in these stores is well trained to assist customers regarding the details of products and understand their benefits and characteristics before purchasing, which draws a consistent set of customers, earning their loyalty. The above-mentioned features of specialty stores are increasing its demand, thereby driving the Asia Pacific dietary supplements market.
The overall Asia Pacific dietary supplements market size has been derived using primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the APAC dietary supplements market. The process also serves the purpose of obtaining overview and forecast for the APAC dietary supplements market with respects to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, and to gain more analytical insights into the topic. The participants who typically take part in such a process include industry expert such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the APAC dietary supplements market. Abbott; Abbott; Amway Corp.; Bayer AG; Bionova; GlaxoSmithKline plc.; Otsuka Holdings Co., Ltd; Pfizer Inc.; and The Bountiful Company are a few key players operating in the APAC dietary supplements market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC dietary supplements market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC dietary supplements market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the dietary supplements market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook